The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
The Scientist
Most Recent
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
After undergoing untested cosmetic surgery that uses stem cells to rejuvenate skin, a woman grew bone fragments in the flesh around one of her eyes.
Fat cells behave differently in obese individuals, causing inflammation and insulin resitance.
The healing powers of maggots may lie in their secreted proteins, which restrain the human immune response.
The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.
The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
Adipose tissue plays an immune role in individuals of normal wieght.
Biomedical groups propose a simplified system for the disclosure of potential conflicts of interests.
Contributors
| December 1, 2012
Meet some of the people featured in the December 2012 issue of The Scientist.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
